IGFALS suppresses hepatocellular carcinoma progression by stabilizing PPAR-γ

This publication has 38 references indexed in Scilit:

• Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024
• Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's disease
  Alzheimer's & Dementia, 2020
• PPARγ Coactivator‐1α Suppresses Metastasis of Hepatocellular Carcinoma by Inhibiting Warburg Effect by PPARγ–Dependent WNT/β‐Catenin/Pyruvate Dehydrogenase Kinase Isozyme 1 Axis
  Hepatology, 2020
• Inactivation of the Ras/MAPK/PPARγ signaling axis alleviates diabetic mellitus-induced erectile dysfunction through suppression of corpus cavernosal endothelial cell apoptosis by inhibiting HMGCS2 expression
  Endocrine, 2018
• Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide
  International Journal of Cancer, 2018
• miR-107-mediated decrease of HMGCS2 indicates poor outcomes and promotes cell migration in hepatocellular carcinoma
  The International Journal of Biochemistry & Cell Biology, 2017
• WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation
  Cancer Letters, 2015
• Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors
  Hepatology, 2012
• Inhibitory Role of Peroxisome Proliferator-Activated Receptor Gamma in Hepatocarcinogenesis in Mice and in Vitro
  Hepatology, 2010
• Interleukin-1β Suppresses Growth Hormone-Induced Acid-Labile Subunit mRNA Levels and Secretion in Primary Hepatocytes
  Biochemical and Biophysical Research Communications, 1998